Sophia Delicou: How Does Lifelong Transfusion Therapy Affect Everyday Life of Adults with Hemoglobinopathies
Sophia Delicou, Clinical Hematologist and Head of the Thalassemia and Sickle Cell Unit at Hippocration General Hospital, Athens, shared on LinkedIn about a recent article she and her colleagues co-authored, published in Transfusion Clinique et Biologique:
”New Publication
How does lifelong transfusion therapy affect the everyday life of adults with hemoglobinopathies?
Our newly published article, ‘Quality of life in patients with transfusion-dependent hemoglobinopathies: evidence from an Expert Center in Greece,’ highlights the real-world burden of chronic transfusion care, as reported directly by patients.
The study sheds light on key challenges such as frequent hospital visits, treatment adherence, monitoring of iron overload, and ongoing concerns about blood availability, issues that significantly shape daily life beyond clinical outcomes.
Listening to patients’ experiences is essential for developing more organized, patient-centered, and sustainable care pathways.”
Title: Quality of life in patients with transfusion-dependent hemoglobinopathies: evidence from an Expert Centre in Greece
Authors: Sophia Delicou, Aikaterini Xydaki, Maria Moraki, Natalia Karantzanou, Clive Richardson, Constantina Politis
Read the Full Article on Transfusion Clinique et Biologique
Stay updated with Hemostasis Today.
-
Apr 2, 2026, 04:47Augustina Isioma Ikusemoro: A Small Antigen with Big Clinical Consequences
-
Apr 2, 2026, 04:28Mohammed Almohammadi: Etiologic Spectrum and Diagnostic Challenges of Hypocellular Marrow Findings
-
Apr 2, 2026, 04:18Emmanuele Kouvousis: Physical Inactivity as a Leading Global Health Risk
-
Apr 2, 2026, 04:03Robert Lufkin: The Misleading Concept of Metabolically Healthy Obesity in Childhood
-
Apr 1, 2026, 23:00Wolfgang Miesbach: What Goes Wrong When Approved Gene Therapies Get Withdrawn?
-
Apr 1, 2026, 22:00Aurelio Maggio: Congratulations to Mariasanta Napolitano on Her 1st Year Leading the Haematology and Rare Disease Uni tat ”V. Cervello” Hospital
-
Apr 1, 2026, 21:21Shubham Misra: CCL2 As a Potential Biomaker for Post-Stroke Seizures, Epileptiform Discharges and Mortality
-
Apr 1, 2026, 21:00Johns Hopkins All Children’s Hospital Becomes The 1st U.S Pediatric VTE Center of Excellence – NBCA
-
Apr 1, 2026, 20:17Aswin K Mohan: The Most Common Misconceptions on Blood Donation